Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
LENZ Therapeutics Inc (NASDAQ: LENZ) closed the day trading at $20.42 up 11.46% from the previous closing price of $18.32. In other words, the price has increased by $11.46 from its previous closing price. On the day, 0.74 million shares were traded. LENZ stock price reached its highest trading level at $20.48 during the session, while it also had its lowest trading level at $16.535.
Ratios:
For a better understanding of LENZ, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 20.36 and its Current Ratio is at 20.36. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, TD Cowen on March 18, 2025, initiated with a Buy rating and assigned the stock a target price of $60.
On September 27, 2024, Raymond James started tracking the stock assigning a Outperform rating and target price of $37.
On August 12, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $38.H.C. Wainwright initiated its Buy rating on August 12, 2024, with a $38 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 14 ’24 when Chevallard Daniel R. bought 3,188 shares for $15.68 per share. The transaction valued at 49,988 led to the insider holds 3,188 shares of the business.
MCCOLLUM JAMES W bought 31,332 shares of LENZ for $501,093 on May 13 ’24. The Director now owns 525,565 shares after completing the transaction at $15.99 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LENZ now has a Market Capitalization of 562430080 and an Enterprise Value of 375709056.
Stock Price History:
The Beta on a monthly basis for LENZ is 0.74, which has changed by -0.06028533 over the last 52 weeks, in comparison to a change of 0.049593568 over the same period for the S&P500. Over the past 52 weeks, LENZ has reached a high of $38.93, while it has fallen to a 52-week low of $14.42. The 50-Day Moving Average of the stock is -15.55%, while the 200-Day Moving Average is calculated to be -19.78%.
Shares Statistics:
Over the past 3-months, LENZ traded about 196.91K shares per day on average, while over the past 10 days, LENZ traded about 337850 shares per day. A total of 27.52M shares are outstanding, with a floating share count of 22.61M. Insiders hold about 17.89% of the company’s shares, while institutions hold 79.08% stake in the company. Shares short for LENZ as of 1741910400 were 2596551 with a Short Ratio of 13.19, compared to 1739491200 on 2555042. Therefore, it implies a Short% of Shares Outstanding of 2596551 and a Short% of Float of 17.989999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
